Key facts
- Spence’s last known valuation is $2.0M (Jan 2017).
- It has raised $5.6M; the latest was Seed Round ($4.2M) in Mar 2025.
- Notable investors include ARTIS (San Francisco), Cedars-Sinai Accelerator, Luminary Labs, TI Capital Management.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Spence
- ·The full record, as it builds
Funding rounds
No funding rounds for Spence are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Spence
Developer of a cloud-based platform designed to enhance patient care and reduce healthcare costs. The company's platform offers patient adherence and improves patient satisfaction by fast, simple, and accurate segmentation, determines their likelihood to adhere to a treatment plan, and provides visibility and guidance needed to support positive behavioral change in patients, ultimately delivering better care while lowering costs, enabling physicians to communicate with each patient to generate tailored interventions to improve their adherence.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2011
- Employees
- 3
- Website
- heyspence.com/
- Ownership
- Privately Held (backing)
Spence doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Spence shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Spence in its N-PORT filings yet. We sweep new filings monthly.